Metal amino acid framework (MAF)-mediated macrophage depletion and reprogramming for arthritis treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Immune cells in cancer · HIV Research and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Evolving concepts of rheumatoid arthritis10.1038/nature01661 ↗
2. Extra-articular manifestations of rheumatoid arthritis: an update10.1016/j.autrev.2011.09.001 ↗
3. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B ↗
4. The immunology of rheumatoid arthritis10.1038/s41590-020-00816-x ↗
5. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis10.1038/s41584-018-0109-2 ↗
6. Rheumatoid arthritis
7. Nanoengineered therapy aiming at the etiology of rheumatoid arthritis10.1016/j.nantod.2021.101367 ↗
8. Macrophage heterogeneity in the context of rheumatoid arthritis10.1038/nrrheum.2016.91 ↗
9. Cytokines in the pathogenesis of rheumatoid arthritis and collagen-induced arthritis10.1007/978-1-4615-0171-8_11 ↗
10. The interplay between monocytes/macrophages and CD4(+) T cell subsets in rheumatoid arthritis10.3389/fimmu.2015.00571 ↗
11. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization10.1016/j.biomaterials.2020.120390 ↗
12. Methotrexate and its mechanisms of action in inflammatory arthritis10.1038/s41584-020-0373-9 ↗
13. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers10.1038/nrrheum.2016.175 ↗
14. Methotrexate: a detailed review on drug delivery and clinical aspects10.1517/17425247.2012.642362 ↗
15. Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis10.1038/nrrheum.2010.179 ↗
16. Rational design of metal-organic frameworks to deliver methotrexate for targeted rheumatoid arthritis therapy10.1016/j.jconrel.2020.10.069 ↗
17. Radicals scavenging MOFs enabling targeting delivery of siRNA for rheumatoid arthritis therapy10.1002/smll.202202604 ↗
18. Core-shell reactor partitioning enzyme and prodrug by ZIF-8 for NADPH-sensitive in situ prodrug activation10.1002/anie.202314025 ↗
19. Nanoscale coordination polymers for synergistic NO and chemodynamic therapy of liver cancer10.1021/acs.nanolett.9b01093 ↗
20. One stone two birds: Redox-sensitive co-localized delivery of cisplatin and nitric oxide through cascade reactions10.1021/jacsau.2c00390 ↗
21. One-pot preparation of peptide-doped metal–amino acid framework for general encapsulation and targeted delivery10.1021/acsami.0c22194 ↗
22. Twin defect-rich Pt ultrathin nanowire nanozymes alleviate inflammatory skin diseases by scavenging reactive oxygen species10.1016/j.redox.2024.103055 ↗
23. D. M. Hercules, Surface spectroscopic characterization of the interaction between zinc ions and γ-alumina10.1016/0021-9517(84)90372-5 ↗
24. Platinum disulfide by XPS10.1116/1.1247731 ↗
25. Nanoparticle cluster gas sensor: Pt activated SnO2 nanoparticles for NH3 detection with ultrahigh sensitivity10.1039/C5NR03585F ↗
26. Surfactant-free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis10.1021/acsnano.0c00364 ↗
27. Efficient and targeted drug/siRNA co-delivery mediated by reversibly crosslinked polymersomes toward anti-inflammatory treatment of ulcerative colitis (UC)10.1007/s12274-019-2274-2 ↗
28. Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis10.1016/j.biomaterials.2015.05.028 ↗